Recombinant Mouse Glial fibrillary acidic Protein (Baculovirus)

Glial fibrillary acidic protein (GFAP) is a key intermediate filament protein primarily expressed in astrocytes, a type of glial cell in the central nervous system. GFAP plays a crucial role in maintaining the structural integrity of glial cells and is involved in various physiological processes, including neuroinflammation, neuroprotection, and the response to injury. Research into GFAP has gained momentum due to its significance as a biomarker for various neurological disorders, such as multiple sclerosis, Alzheimer's disease, and traumatic brain injury. Elevated levels of GFAP in the cerebrospinal fluid (CSF) or serum have been associated with glial activation and can indicate the severity of neurodegeneration or injury. Moreover, GFAP is involved in the formation of astrocytic scars, which can influence neuronal regeneration and recovery following CNS damage. Recombinant forms of GFAP have been developed to better understand its structure-function relationships and to explore its potential therapeutic applications. Studies using recombinant GFAP have provided insights into its role in cell signaling, its impact on astrocyte behavior, and its interactions with other proteins in the CNS. As research progresses, GFAP continues to be a focal point in understanding glial biology and its implications for treating and diagnosing neurological diseases, making it a promising target for future therapeutic interventions.